Evidence map›Paper›PMID 31372008›Full record

ArticleInfection and drug resistance2019

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections.

Pallam Gopichand, Girija Agarwal, Mailan Natarajan, Jharna Mandal, Surendran Deepanjali, Sreejith Parameswaran, L N Dorairajan

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Prevalence of Multidrug-ResistantIndian journal of microbiology · 2024
    Article
  10. Article
  11. Article
  12. Intravenous Fosfomycin for Systemic Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023
    Review
  13. Multifunctional FeMolecules (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. In Vitro Susceptibility of Multi-Drug ResistantPathogens (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Pallam GopichandDepartment of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
Girija AgarwalJawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) , Pondicherry, India.
Mailan NatarajanDepartment of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
Jharna MandalDepartment of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
Surendran DeepanjaliDepartment of Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
Sreejith ParameswaranDepartment of Nephrology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
L N DorairajanDepartment of Urology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India.
Jawaharlal Institute of Post Graduate Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRising rates of resistance to antimicrobial drugs among MATERIALS AND

methodsA total of 326 multidrug-resistant (MDR) isolates comprising of

resultsThe MIC50 for meropenem (0.5 µgm/mL) and nitrofurantoin (32 µgm/mL) was within the susceptible range only for

conclusionFosfomycin showed a good inhibitory effect on the biofilms produced by the MDR organisms studied here.

Indexed as

biofilmfosfomycinMDRMICUTI

Identifiers

PMID31372008
PMCPMC6628599
OpenAlexW2956401396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.